SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-009104
Filing Date
2021-05-05
Accepted
2021-05-05 16:34:17
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arna-20210331.htm   iXBRL 10-Q 1101428
2 EX-10.1 arna-20210331xex101.htm EX-10.1 149149
3 EX-31.1 arna-20210331xex311.htm EX-31.1 9353
4 EX-31.2 arna-20210331xex312.htm EX-31.2 8034
5 EX-32.1 arna-20210331xex321.htm EX-32.1 6107
  Complete submission text file 0001628280-21-009104.txt   4854579

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20210331.xsd EX-101.SCH 26837
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arna-20210331_cal.xml EX-101.CAL 54616
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arna-20210331_def.xml EX-101.DEF 130961
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20210331_lab.xml EX-101.LAB 411872
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20210331_pre.xml EX-101.PRE 259025
11 EXTRACTED XBRL INSTANCE DOCUMENT arna-20210331_htm.xml XML 711136
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 21893958
SIC: 2834 Pharmaceutical Preparations